Health

WHITE HOUSE SUPPORTS CDC GUIDELINES FOR CIVILIANS, EXPLAINS DIFFERENT TREATMENT FOR U.S. TROOPS

NEW YORK TIMES                                                              Oct. 28, 2014
By MICHAEL D. SHEAR

WASHINGTON — President Obama on Tuesday said that new Ebola guidelines from the Centers for Disease Control and Prevention were “sensible, based in science” and would help keep Americans safe while not discouraging volunteers from traveling to West Africa to battle the disease at its source....

ASSOCIATED PRESS                                                                     Oct. 28, 2014
By RODNEY MUHUMUZA

KAMPALA, Uganda--Athorities are having trouble figuring out how many more people are getting Ebola in Liberia and Sierra Leone and where the hot spots are in those countries, harming efforts to get control of the raging, deadly outbreak, the U.N.'s top Ebola official in West Africa said Tuesday.

"The challenge is good information, because information helps tell us where the disease is, how it's spreading and where we need to target our resources," Anthony Banbury told The Associated Press by phone from the Ghanaian capital of Accra, where the U.N. Mission for Ebola Emergency Response, or UNMEER, is based.

Health experts say the key to stopping Ebola is breaking the chain of transmission by tracing and isolating those who have had contact with Ebola patients or victims. Health care workers can't do that if they don't know where new cases are emerging.

"And unfortunately, we don't have good data from a lot of areas. We don't know exactly what is happening," said Banbury, the chief of UNMEER.

ASSOCIATED PRESS                                 Oct. 28, 2014
  GENEVA-- The Swiss agency that regulates new drugs said Tuesday it has approved an application for a clinical trial with an experimental Ebola vaccine at the Lausanne University Hospital.

In this picture provided by the World Health Organization, a package of vials of the first shipment of the experimental vaccine VSE-EBOV is opened at the Geneva Cantonal hospital on Wednesday, Oct. 22, 2014. The World Health Organization (WHO) welcomes the donation by the government of Canada of 800 vials of an experimental candidate vaccine, VSV-EBOV, against Ebola virus disease. Clinical safety trials with this experimental Ebola vaccine have already begun in healthy human volunteers in Mali, the United Kingdom and the United States after showing very promising results in animal research. . (AP Photo/WHO/Mathilde Missioneiro) 

Swissmedic said the trial will be conducted among 120 volunteer participants with support from the U.N. World Health Organization. The experimental vaccine is to be initially administered on healthy volunteers who will be sent as medical staff to fight the Ebola epidemic in West Africa.

UPDATE WITH DETAILS OF MARYLAND AND VIRGINIA MONITORING  (Scroll down)

ROUNDUP OF DEVELOPMENTS IN THE QUARANTINE  DISPUTE
NEW YORK TIMES                        Oct. 28, 2014

By SABRINA TAVERNISE, MICHAEL D. SHEAR and HELENE COOPER

The federal government on Monday tried to take charge of an increasingly acrimonious national debate over how to treat people in contact with Ebola patients by announcing guidelines that stopped short of tough measures in New York and New Jersey and were carefully devised, officials said, not to harm the effort to recruit badly needed medical workers to West Africa.